
Bioengineered Artificial Skin Market
Description
Bioengineered Artificial Skin Market, By product type (Bilayered Bioengineered Artificial Skin , Trilayered Bioengineered Artificial Skin, Others), By Application (Chronic Wounds, Acute Wounds, Others), By End User (Hospitals, Clinics, Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Bioengineered skin is designed to take over the functions of the epidermis and/or dermis until the patient's skin barrier spontaneously repairs itself. Bioengineered skin autografts are derived from the patient's own skin cells that are grown or cultured in small amounts of skin or hair follicles. Bioengineered artificial skin is designed for the reconstruction of skin appendages, pigmentation, and nerves. Artificial skin can replace or can be used to replace the outer layer of the skin or the thick layer just underneath it (epidermis and dermis).Market Dynamics:
Rise in number of road accidents, burns, and trauma-related incidents, high incidence of acute and chronic wounds (owing to the rise in burden of chronic diseases and growing geriatric population), increasing awareness among people about various skin treatments, and rise in demand for artificial skin are major factors expected to drive growth of the global bioengineered artificial skin market.
For instance, in June 2021, the U.S. Food and Drug Administration (FDA) approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns). StrataGraft is produced from two kinds of human skin cells (keratinocytes and dermal fibroblasts) grown together to make a bi-layered construct (a cellularized scaffold).
Key features of the study:
- This report provides in-depth analysis of the global bioengineered artificial skin market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global bioengineered artificial skin market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include ConvaTec Group plc, LifeNet Health, Zimmer Biomet Holdings, Inc., Medline Industries, Inc., Acelity L.P. Inc., Johnson & Johnson, Stryker Corporation, TissueTech, Inc., Stratatech Corporation, Avita Medical, Mölnlycke Health Care AB, MiMedx Group, Inc., Organogenesis Holdings Inc., Smith & Nephew plc, and Integra LifeSciences Holdings Corporation, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global bioengineered artificial skin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioengineered artificial skin market.
- Global Bioengineered Artificial Skin Market, By Product Type:
Trilayered Bioengineered Artificial Skin
Others
- Global Bioengineered Artificial Skin Market, By Application:
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Others
- Burns
- Surgical Wounds
- Others
- Global Bioengineered Artificial Skin Market, By End User:
Clinics
Others
- Global Bioengineered Artificial Skin Market, By Geography:
Europe
Asia Pacific
Latin America
Middle East & Africa
- Company Profiles:
LifeNet Health
Zimmer Biomet Holdings, Inc.
Medline Industries, Inc.
Acelity L.P. Inc.
Johnson & Johnson
Stryker Corporation
TissueTech, Inc.
Stratatech Corporation
Avita Medical
Mölnlycke Health Care AB
MiMedx Group, Inc.
Organogenesis Holdings Inc.
Smith & Nephew plc
Integra LifeSciences Holdings Corporation
Table of Contents
165 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in number of road accidents, burns, and trauma-related incidents
- High cost of treatment
- High incidence of acute and chronic wounds
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Global Bioengineered Artificial Skin Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Global Bioengineered Artificial Skin Market, By Product Type, 2017-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Bilayered Bioengineered Artificial Skin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- Trilayered Bioengineered Artificial Skin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- 6. Global Bioengineered Artificial Skin Market, By Application, 2017-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Chronic Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Pressure Ulcers
- Others
- Acute Wounds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- Burns
- Surgical Wounds
- Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- 7. Global Bioengineered Artificial Skin Market, By End User, 2017-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
- 8. Global Bioengineered Artificial Skin Market, By Geography, 2017-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
- 9. Competitive Landscape
- ConvaTec Group plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LifeNet Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zimmer Biomet Holdings, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medline Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Acelity L.P. Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stryker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- TissueTech, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stratatech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Avita Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mölnlycke Health Care AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MiMedx Group, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Organogenesis Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Smith & Nephew plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Integra LifeSciences Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
- 10. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on "Global Bioengineered Artificial Skin Market” - forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.